Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2021 Jan 29;17(1):e1009321. doi: 10.1371/journal.pgen.1009321

Regulating the expression of gene drives is key to increasing their invasive potential and the mitigation of resistance

Andrew Hammond 1,2, Xenia Karlsson 1, Ioanna Morianou 1, Kyros Kyrou 1, Andrea Beaghton 1, Matthew Gribble 1, Nace Kranjc 1, Roberto Galizi 1, Austin Burt 1, Andrea Crisanti 1,3,*, Tony Nolan 4,*
Editor: Owain Rhys Edwards5
PMCID: PMC7886172  PMID: 33513149

Abstract

Homing-based gene drives use a germline source of nuclease to copy themselves at specific target sites in a genome and bias their inheritance. Such gene drives can be designed to spread and deliberately suppress populations of malaria mosquitoes by impairing female fertility. However, strong unintended fitness costs of the drive and a propensity to generate resistant mutations can limit a gene drive’s potential to spread.

Alternative germline regulatory sequences in the drive element confer improved fecundity of carrier individuals and reduced propensity for target site resistance. This is explained by reduced rates of end-joining repair of DNA breaks from parentally deposited nuclease in the embryo, which can produce heritable mutations that reduce gene drive penetrance.

We tracked the generation and selection of resistant mutations over the course of a gene drive invasion of a population. Improved gene drives show faster invasion dynamics, increased suppressive effect and later onset of target site resistance. Our results show that regulation of nuclease expression is as important as the choice of target site when developing a robust homing-based gene drive for population suppression.

Author summary

Gene drives are selfish genetic elements that are able to drastically bias their own inheritance. They can rapidly invade populations, even starting from a very low frequency.

Recent advances have allowed the engineering of gene drives deliberately designed to spread genetic traits of choice into populations of malaria-transmitting mosquito species–for example traits that impair a mosquito’s ability to reproduce or its ability to transmit parasites.

The class of gene drive in question uses a very precise cutting and copying mechanism, termed ‘homing’, that allows it to increase its numbers in the cells that go on to form sperm or eggs, thereby increasing the chances that a copy of the gene drive is transmitted to offspring.

However, while this type of gene drive can rapidly invade a mosquito population, mosquitoes can also eventually become resistant to the gene drive in some cases. Here we show that restricting the cutting activity of the gene drive to the germline tissue is crucial to maintaining its potency and we illustrate how failure to restrict this activity can lead to the generation of mutations that can make mosquitoes resistant to the gene drive.

Introduction

Gene drives and malaria control

Gene drives are genetic elements that are capable of biasing their own inheritance, allowing their autonomous spread in a population, even from a very low initial frequency. Coupling a trait of interest to a drive element is a way of deliberately modifying a population, potentially in a very short timeframe. In the case of the mosquito vector of malaria, gene drives have been proposed to spread traits that either interfere with the mosquito’s capacity to reproduce, or its capacity to transmit the malaria parasite.

We know that vector control is effective in controlling malaria–the malaria burden was halved in the period 2000–2015 and the vast majority of this gain was achieved through targeting the vector with conventional insecticide-based approaches (bednets and residual spraying) [1]. However, resistance to insecticides is stalling these gains [2]. Gene drive is a technology with the potential to augment and complement existing control approaches in a self-sustaining way.

Endonuclease-based homing gene drives

Gene drives based on site-specific endonucleases were first proposed over 15 years ago [3] and recent advances in CRISPR technology have led to several demonstrations that this endonuclease, which is easy to reprogram to recognise a genomic site of choice, can be repurposed as a gene drive [4,5].

The premise is that the endonuclease is sufficiently specific to recognise a DNA target sequence within a region of interest and the gene encoding the endonuclease is inserted within this target sequence on the chromosome, thereby rendering it immune to further cleavage. When a chromosome containing the endonuclease is paired with a chromosome containing the wild-type target site, the site is cleaved to create a double stranded break (DSB) that can be repaired, either through simple ‘cut and shut’ non-homologous end-joining (NHEJ) or through homology-directed repair (HDR). HDR involves strand invasion from the broken strand into regions of immediate homology on the intact chromosome, and synthesis across the intervening region to repair the gap. In the arrangement described this can lead to copying of the endonuclease, and its associated allele, from one chromosome to another in a process referred to as ‘homing’. If homing takes place in the germline then inheritance of the gene drive is biased because the majority of sperm or eggs produced in the germline will inherit the drive, on either the original gene drive-carrying chromosome or the newly converted chromosome. The rate of spread of this type of gene drive is thus a product of the rate of germline nuclease activity and the probability with which double stranded breaks are repaired by the host cell using HDR rather than end-joining repair.

Previous limitations of CRISPR-based homing gene drives

We and others have tested several gene drives designed to suppress or modify mosquito populations [68]. With any gene drive the force of selection for resistance to the drive will be proportional to the fitness cost imposed by the drive. In the case of population suppression approaches, this selection falls on the mosquito. We previously built several CRISPR-based gene drives designed to achieve population suppression through disrupting female fertility genes and demonstrated their spread throughout caged populations of the malaria mosquito, Anopheles gambiae [7]. However, the drive was eventually replaced in the population by resistant mutations generated by end-joining repair in the fraction of cleaved chromosomes that were not modified by homing [9]. To ultimately replace the drive in a population, these mutations must also encode a functional copy of the target gene so that they restore fertility to females.

In determining the propensity for target site resistance to arise, the amount of functional constraint at the target site determines the degree of variation that can be tolerated there. In the first iteration of a population suppression gene drive that we built, the target site sequence is poorly conserved [7], suggesting little functional constraint, and therefore is particularly prone to accommodating resistant alleles that restore function to the target gene (‘r1’ alleles, as opposed to ‘r2’ alleles which are resistant to cleavage but do not restore function to the target gene) (S1 Fig) [9,10]. The importance of choosing functionally constrained sites was shown when a gene drive targeting a highly conserved target sequence in the female-specific isoform of a sex determination gene was able to crash caged populations without selecting for resistant mutations of the r1 class [8]. Notwithstanding this success, it is unlikely that any single site will be completely ‘resistance-proof’. This is true for any suppressive technology, from antibiotics to insecticides, and measures to prolong the durability of these interventions need to be considered at inception.

In addition to multiplexing gene drives to recognise more than one target site [3,4,11,12], akin to combination therapy with antibiotics, it is necessary to reduce the relative contribution of the error-prone end-joining repair pathway, over HDR, since this can serve to increase the range and complexity of potential resistant alleles on which selection could act.

Cleavage by maternally deposited nuclease in the embryo is believed to be the major source of end-joining mutations in current gene drive designs [6,9,13]. We have previously observed high levels of end-joining repair in the embryo following strong maternal deposition using the vas2 promoter. This is likely a consequence of germline expression that persists through oocyte development leading to perduring Cas9 transcript and/or protein in the newly fertilised embryo. Additionally, using the same promoter, unrestricted activity of the endonuclease outside of the mosquito germline caused a strong unintended fitness cost in females harbouring a single copy of the gene drive, due to partial conversion of the soma to the homozygosity for a null allele. These fitness effects retarded the invasive potential of the drive for two reasons: 1- reduced bias in inheritance each generation due to low fecundity of drive-carrying (heterozygous) females; 2- increased selection pressure for resistant mutations [9].

We tested a suite of germline promoters for their ability to restrict nuclease activity to the germline and their ability to limit the generation of resistance. We employed genetic screens to get a quantitative determination of the range of mutations arising when gene drive constructs are driven by the different promoters as well as where and how these mutations were generated.

One of the promoters characterised here has previously been used in a gene drive construct that was able to successfully eliminate a laboratory population of mosquitoes [8]. Importantly, we quantify here the magnitude of the improvement in gene drive performance afforded by choice of this promoter and the resulting improved regulation of expression alone, rather than choice of gene drive target. We then employed the best performing constructs in a cage invasion assay to determine how our single generation estimates of homing performance translated to our mathematical models of penetrance and population suppression over time, while tracking the emergence of resistant alleles under selection.

Our results show that the regulation of nuclease expression is a key aspect in ensuring the robustness and efficacy of homing-based gene drive systems for population control.

Results and discussion

Choice of germline promoters

To find alternatives to the vas2 promoter, we investigated three mosquito genes, AGAP006241 (zero population growth, zpg), AGAP006098 (nanos, nos) and AGAP007365 (exuperantia, exu), that are expressed in the germline of male and female Anopheles gambiae [14] and may show reduced somatic expression or deposition into the embryo.

In Drosophila the gene zpg is specifically expressed in the male and female germline, where it mediates the formation of gap junctions between the developing germline and cyst cells [15]. The mosquito ortholog of zpg shows a similar expression pattern [14] and appears to be functionally conserved as it is essential for both male and female gonad development [16]. Exu and nos are maternal effect genes in Drosophila that are transcribed in the oocyte and deposited into the early embryo [1719]. Crucially, deposited nos and zpg mRNA concentrate at the germ plasm due to regulatory signals present on the untranslated regions, which also further restrict translation of maternal mRNAs to the germline [15,20]. The promoter region of exuperantia has been validated in Drosophila [21] and in the tiger mosquito, Aedes aegypti, has been used to drive robust expression in both male and female germlines and has recently been used to control expression of Cas9 in a split gene drive system in this mosquito [22,23]. In contrast to zpg and exu, several reports have suggested that nos is specific to the female germline in mosquitoes, however promoter fusions in Aedes aegypti and Anopheles gambiae led to low level expression in males perhaps due to incomplete recapitulation of endogenous gene expression [2426].

Generation of new gene drives designed to restrict spatiotemporal expression to the mosquito germline

To determine the effect of transcriptional control of gene drive activity, we tested the new constructs at a previously validated female fertility locus that was prone to resistance [9], in order to quantify any reduction in the creation or selection of resistant mutations that resulted from reducing embryonic end-joining and improving female fertility, respectively.

The target site in question resides within the gene AGAP007280 (Fig 1A), an ortholog of the Drosophila gene nudel required in the follicle cells to define polarity of the eggshell [27,28]. Null mutations at this target site cause a recessive female sterile phenotype. The active gene drive cassette (CRISPRh) used previously to target AGAP007280 [7] was modified to contain Cas9 under control regulatory sequences flanking upstream and downstream of either zpg, nos or exu genes. The CRISPRh constructs were inserted within the AGAP007280 target site, by recombinase-mediated cassette exchange, as previously [7] (Fig 1B). The new gene drive strains were named nos-CRISPRh, zpg-CRISPRh, exu-CRISPRh, respectively.

Fig 1. Target site and design of new CRISPRh gene drives designed to express Cas9 under regulation of zpg, nos and exu germline promoters.

Fig 1

(A) The haplosufficient female fertility gene, AGAP007280, and its target site in exon 6 (highlighted in grey), showing the protospacer-adjacent motif (highlighted in teal) and cleavage site (red dashed line). (B) CRISPRh alleles were inserted at the target in AGAP007280 using φC31-recombinase mediated cassette exchange (RMCE). Each CRISPRh RMCE vector was designed to contain Cas9 under transcriptional control of the nos, zpg or exu germline promoter and terminator, a gRNA targeted to AGAP007280 under the control of the ubiquitous U6 PolIII promoter, and a 3xP3::DsRed marker.

Zpg and nos promoters drive high levels of homing in the germline and vary in magnitude of maternal effect

Germline gene drive activity that leads to homing is expected to cause super-Mendelian inheritance of the drive. However, maternally-deposited Cas9 has the potential to cause resistant mutations in the embryo that may reduce the rate of homing during gamete formation (if the mutations occur in germline precursor cells) or reduce fertility (due to somatic mosaicism of null mutations in the target fertility gene) [6,9,10,13,29].

Assays were performed to measure the transmission rates and fertility costs associated with each of three drives (Fig 2). Individuals heterozygous for the gene drive were crossed to wild type and their progeny scored for the presence of the DsRed marker gene linked to the construct. To test the magnitude of any parental effect, gene drive carriers were separated according to whether they received their gene drive allele paternally or maternally. Data from our previously generated gene drive constructs under control of the vasa promoter (vas2-CRISPRh) served as a benchmark [7].

Fig 2. Comparison of fecundity and homing rates in mosquitoes containing Cas9-based gene drives under regulation of zpg, nos and exu germline promoters.

Fig 2

Phenotypic assays were performed to measure fecundity and transmission rates for each of three drives. CRISPRh heterozygotes of both sexes were crossed to wild type (panel A, F1) and their CRISPRh heterozygous progeny were subsequently also crossed to wild type (A, F2). The larval progeny (F3) of the F2 cross were counted to determine the fecundity of CRISPRh heterozygotes (F2), depending on whether they inherited the gene drive from male or female parents (F1) (A right, C, E, G, I). The larval progeny (F3) were also scored for the presence of DsRed linked to the construct to determine gene drive transmission rates of CRISPRh heterozygotes (F2), depending on whether they inherited the gene drive from male or female parents (F1) (A left, B, D, F, H). Each data point represents one clutch from one individual F2 female. Average transmission rates are shown on the right of panels B, D, F, H (Mann-Whitney test, ****: p < 0.0001, ***: p < 0.001, *: p < 0.05, ns: non-significant), and relative fecundity to wild type is depicted on the right of panels C, E, G, I (Kruskal-Wallis test, ****: p < 0.0001, ***: p < 0.001, **: p < 0.01, ns: non-significant). Males and females were further separated by whether they had inherited the CRISPRh construct from either a male or female parent (Mann-Whitney test, ****: p < 0.0001, ***: p < 0.001, *: p < 0.05, ns: non-significant). For example, ♂→♀ denotes the progeny count and gene drive transmission rates in the progeny of a heterozygous CRISPRh female that had inherited the drive allele from a heterozygous CRISPRh male, when crossed to a wild-type male. High levels of homing were observed in the germline of zpg-CRISPRh and nos-CRISPRh males and females, however the exu promoter generated only moderate levels of homing in the germline of males but not females (Mann-Whitney test, p < 0.0001). The significant maternal effect upon homing performance in offspring previously seen for vas2-CRISPRh (Hammond et al., 2017, reproduced here in panel B) was also observed in nos-CRISPRh, but not for zpg-CRISPRh (Mann-Whitney test, ****: p < 0.0001, **: p < 0.001, *: p < 0.05, ns: non-significant). Counts of hatched larvae for the individual crosses revealed improvements in the fertility of heterozygous females containing CRISPRh alleles based upon zpg, nos and exu promoters compared to the vas2 promoter. Phenotypic assays were performed on G2 and G3 for zpg, G3 and G4 for nos, and G15 for exu. ♀* denotes vas2-CRISPRh females that were heterozygous for a resistance (r1) allele, these were used because heterozygous vas2-CRISPRh females are usually sterile. ND = not determined.

When the gene drive was received paternally zpg-CRISPRh transmission rates of 93.5% (±1.5% s.e.m.) in males and 97.8% (±0.6% s.e.m.) in females were observed, falling only slightly below the vas2-CRISPRh rates in the equivalent cross (99.6% ±0.3% s.e.m. in males and 97.7% ±1.6% s.e.m. in females) (Fig 2D and 2B). The paternally-received nos-CRISPRh construct showed comparable rates to vas2-CRISPRh, with 99.6% (±0.3% s.e.m.) inheritance in females and 99.1% (±0.3% s.e.m.) inheritance in males (Fig 2F). In contrast, paternally-received exu-CRISPRh showed only modest homing rates in males (65.0% ±2.0% s.e.m. transmission rate) and no homing in females (Fig 2H).

When the gene drive was received maternally, the vas2-CRISPRh constructs showed a large reduction in homing in males (60.2% ±1.9% s.e.m. inheritance rate, equivalent to homing of 20.4% of non-drive chromosomes) compared to those that received the drive paternally (99.2% homing of non-drive chromosomes) (Fig 2B) (Mann-Whitney test, p<0.0001). On the contrary, for the zpg-CRISPRh construct, we saw minimum transmission rates of 90.6% (±1.8% s.e.m.) in males and a higher rate of 99.1% in females (±0.4% s.e.m.) (Mann-Whitney test, p = 0.0019), yet no significant maternal or paternal effect (p>0.9999) (Fig 2D). With the nos-CRISPRh construct, though homing rates were still high, we saw a maternal effect leading to reduction in homing performance in females (85.2% ±5.0% s.e.m. vs 99.6% ±0.3% s.e.m., respectively, Mann-Whitney test, p = 0.0006) and a similar but non-significant reduction in males (83.6% ±5.0% s.e.m. inheritance when inherited maternally vs 99.1% ±0.4% s.e.m. when paternally inherited, Mann-Whitney test, p = 0.066) (Fig 2F). This suggests that Cas9 from the nos-CRISPRh construct is maternally deposited, though to a lesser extent than the vas2-CRISPRh constructs, and active in a way that leads to the formation of alleles in the zygotic germline that are resistant to homing in the next generation. Finally, maternally-inherited exu-CRISPRh constructs showed modest homing rates in males (63.1% ±2.4% s.e.m. inheritance), unaffected by parental effects, though the absence of gene drive activity in females (51.8% ±1.7% s.e.m. inheritance) may imply that there was simply insufficient nuclease expression in the female germline to produce a maternal effect (Fig 2H).

New gene drive constructs confer significantly less fecundity costs in carrier females than previous constructs

Fecundity assays were performed to quantify the number of viable progeny (measured as larval output) in individual crosses of drive heterozygotes mated to wild type (Fig 2). Our previously published data for vas2-CRISPRh females showed vastly impaired fecundity (8% fecund, relative to wild type) in females heterozygous for this construct at the AGAP007280 locus, despite this gene showing full haplosufficiency for this phenotype (i.e. individuals heterozygous for a simple null allele show normal fecundity) [7]. The most parsimonious explanation for this fitness effect is the (partial) conversion of the soma to the null phenotype, due to two sources: somatic ‘leakiness’ of the putative germline promoter driving the Cas9 nuclease and/or the stochastic distribution (mosaicism) across the soma of nuclease parentally deposited into the embryo.

Both the zpg-CRISPRh and the nos-CRISPRh drives showed a general marked improvement in relative female fecundity over the previous vas2-driven construct, with maximal fecundities (relative to wild type) of 54.9% and 55.5%, respectively (Fig 2E and 2G). Although we observed significant maternal deposition from the nos-CRISPRh construct, the reduction in fecundity of females that received the gene drive maternally was non-significant, compared to those that received the drive paternally (39.7% ±8.5% s.e.m. vs 55.5% ±7.3% s.e.m. larval output, respectively) (Fig 2G). For this construct we also noted a general reduction in male fecundity, regardless of paternal source of the gene drive allele. For zpg-CRISPRh we observed no reduction in male fecundity and the reduction in female fecundity was not subject to any maternal effect, consistent with the absence of maternal effect on homing for the same construct. Thus, the most likely explanation for the improved performance of the zpg-CRISPRh gene drive is the lack of a maternal effect, though the incomplete restoration of full fecundity in heterozygote females suggests there may still be some somatic leakiness.

The reason for the observed lower fecundity in nos-CRISPRh males is unexplained, given that the target gene affects female fertility. Possible explanations might include some unknown feature of the exogenous nanos promoter that affects sperm quality or general reduced fitness resulting from the transgenesis procedure itself. We also note that the measure of fecundity in these experiments is marked by high inter-experimental variability and that, despite the inclusion of a wild-type control every time, we cannot exclude the possibility that batch effects can contribute in part to some of the differences observed between lines.

Embryonic and germline rates of end-joining induced by gene drives containing zpg and nos promoters

Given its importance in the generation of resistant alleles, we designed a genetic screen to quantify the magnitude of parental nuclease deposition from each construct (Fig 3A). In this screen the wild-type target allele in the embryo, balanced against a pre-existing r1 allele (a 6bp GAGGAG deletion) is only exposed to a paternal or maternal dose of the nuclease in the absence of a genetically encoded drive construct. We performed amplicon sequencing of the relevant region of the AGAP007280 target locus to sample and quantify the diversity of alleles at the target site. Two replicates were performed for each cross. In the absence of any Cas9 activity an equal ratio of the wild-type target site and the original r1 allele is expected among the chromosomes amplified. Novel indels arising at the target sequence are indicative of nuclease activity in the zygote as a result of parental deposition. The original r1 allele may also be over-represented among the F2 in this assay due to simple stochastic variation in its Mendelian inheritance or due to deposited Cas9 activity, either as a result of de novo generation through end-joining repair, or as a result of gene conversion through homing of the inherited r1 allele. Taking only the most conservative signal of embryonic end-joining (indels unique from the inherited r1 allele sequence), vas2-CRISPRh generated high levels of maternally deposited Cas9 activity–affecting 70% of all nuclease-sensitive alleles (Figs 3B and S3). In the offspring of nos-CRISPRh females the end-joining rates from maternal deposition were substantially lower (10.5% of nuclease-sensitive alleles), with no significant paternal deposition (Ordinary one-way ANOVA with Dunnett's multiple comparisons test, p = 0.9997). For the zpg-CRISPRh line, we found no significant signal of maternal or paternal deposition (Ordinary one-way ANOVA with Dunnett's multiple comparisons test, p = 0.9564 for zpg females and p = 0.9996 for zpg males) (S3 Fig).

Fig 3. Heritability and rates of formation of mutations caused by parentally deposited nuclease from different gene drive constructs.

Fig 3

(A) zpg-CRISPRh, nos-CRISPRh or vas2-CRISPRh were crossed to a strain homozygous for a defined r1 resistance allele (203-GAGGAG) to generate F1 heterozygotes of genotype GD/r1, containing both the gene drive allele (red bar) and the resistant allele (orange hatched bar). F1 heterozygotes and r1/r1 homozygotes (control) were crossed to wild type and their non-drive F2 progeny analysed by pooled amplicon sequencing across the target site in AGAP007280. The non-drive F2 progeny (r1*/wt) were crossed to wild type, and the entire F3 progeny was analysed by amplicon sequencing to determine the heritability of mutations caused by paternally-derived nuclease. (B) Amplicon sequencing results from F2 individuals (n>128) with genotype WT/r1 (selected by absence of dsRED-linked gene drive allele), whose only source of Cas9 nuclease would be from parental deposition into the embryo. In the absence of any deposited source of nuclease only the original r1 allele and the WT allele are expected, at a ratio of 1:1. Significant deviations from this ratio, or the presence of new target site mutations, therefore indicate the mutagenic activity of deposited Cas9. (C) Amplicon sequencing of F3 progeny deriving from those F2 crossed to wild type, in order to determine the heritability of mutations formed by parentally deposited nuclease. Mendelian inheritance of mutations present in the sampled F2 individuals would be expected to lead to a 2-fold reduction in their frequency between the F2 and F3 samples.

Mutant alleles generated in the embryo, if included in the germline tissue, will be resistant to subsequent homing during the production of gametes in the adult, reducing rates of drive transmission. Indeed, the gradation in terms of maternal contribution to end joining in the embryo (vas2-CRISPRh > nos-CRISPRh > zpg-CRISPRh) mirrors the magnitude of the maternal effect observed in reducing drive transmission for each construct (Fig 2). Consistent with this, the presence in the F3 of novel end-joining mutations that were created in the F2 confirms that deposited nuclease affected also the germline tissue (Fig 3C). However, the frequency of resistant alleles generated in the F2 was approximately halved in the F3, consistent with their simple Mendelian inheritance. This is perhaps best seen by observing the frequency of the original r1 allele in the F2 and subsequently in the F3 of the vas2-CRISPRh line. This indicates that any contribution of deposited nuclease to homing of these alleles in the germline is at best minimal, at least in our experimental setup. This is in contrast to reports in Drosophila, albeit in a split drive system with the gRNA cassette and the source of Cas9 on separate constructs, where use of the nanos promoter can lead to ‘shadow drive’ in which perduring maternally deposited Cas9 can cause homing of the gRNA cassette in the germline even in the absence of genetically encoded Cas9 [30,31].

Given the improved characteristics of the zpg-CRISPRh construct in terms of fecundity and reduced embryonic end-joining we also investigated its propensity to generate end-joining mutants in the germline, a feature that has been observed previously both in mosquitoes and Drosophila [9,13,32]. We designed a genetic cross that allowed us to enrich and capture those chromosomes (~2–3%) that were subjected to the nuclease activity of the zpg-CRISPRh gene drive in the adult germline but were not ‘homed’ (Fig 4). Interestingly from males (n = 239) we noticed a much greater heterogeneity of alleles (82 mutated chromosomes covered by 18 distinct alleles) among those generated from end-joining repair than we did in females (n = 218), where the vast majority (88%) of non-homed chromosomes were mutated but these comprised just 4 unique alleles. The apparent differences in the behaviour of this gene drive between the male and female germlines may reflect differences in the timing of nuclease activity and chromosomal repair in the two sexes. It may also suggest that early repair events in the female germline, when only a few germline stem cells are present and indeed only one of 16 germline cells becomes an oocyte, leads to a clustering of repair events among the eventual gametes [10,13,32].

Fig 4. The rate and outcome of meiotic end-joining (EJ) differs in the male and female germline.

Fig 4

F1 females (n>500) or males (n>200) heterozygous for the gene drive allele (linked to RFP) (GD) were crossed to a GFP-linked ‘docking line’ (DL). The docking line contains a null allele (DL) of the target gene, generated by inserting a full GFP marker cassette at the target site, thereby both truncating the AGAP007280 coding sequence and ablating the target site recognised by the gene drive, while allowing easy visual tracking of this allele. The rare fraction (~3%) of F2 progeny that had inherited a DL but not a GD allele were selected and their non-drive allele (ND), that had been meiotically exposed to nuclease activity, was sequenced to reveal the frequency and nature of EJ mutations taking place during meiosis (offspring from females n = 218; offspring from males n = 239). The frequency of all WT unmodified alleles is shown in grey. Mutant alleles, whose effect had previously been tested by balancing against a null allele, were classified as ‘confirmed r1’ (orange) or ‘confirmed r2’ (blue) and novel mutations, whose phenotype has not yet been definitively proved, as in-frame (light orange) or out-of-frame (light blue).

zpg-CRISPRh spreads close to fixation in caged releases and exerts a large reproductive load on the population

Given its improved fecundity and its lower mutagenic activity we investigated the potential for the zpg-CRISPRh gene drive to spread throughout naïve mosquito populations. Two replicate cages were initiated with either 10% or 50% starting frequency of drive heterozygotes, and monitored for 16 generations, which included pooled sequencing of the target locus at various generations. The drive spread rapidly in all four trials, to more than 97% of the population, achieving maximal frequency in just 4–10 generations (Fig 5A). In each trial, the drive sustained more than 95% frequency for at least 3 generations before its spread was reversed by the gradual selection of drive-resistant alleles. Notably, we observed similar dynamics of spread, in terms of rate of increase and duration of maximal frequency, whether the gene drive was released at 50% or 10%, demonstrating that initial release frequency has little impact (providing it is not stochastically lost initially) upon the potential to spread; i.e. a release of low numbers of mosquitoes with the gene drive can be as effective (if not as quick) at reaching high frequency.

Fig 5. zpg-CRISPRh rates of spread through caged populations, reproductive load and real-time profiling of resistance.

Fig 5

zpg-CRISPRh/+ were released into replicate caged WT populations at 10% (right) or 50% (middle) CRISPRh/+ initial frequency. (A) The frequency of drive-modified mosquitoes (solid line) was recorded each generation by screening larval progeny for presence of DsRed linked to the CRISPRh allele. Entire egg output per generation was also recorded (dashed line). zpg-CRISPRh drive spread was compared to previous results for vas2-CRISPRh (left panel) from Hammond et al. (2017). (B) The nature and frequency of non-drive alleles was determined for several generations (arrows) of the caged population experiments by amplicon sequencing across the target site at AGAP007280 in pooled samples. Vertically aligned panels represent the two replicates from each treatment. The frequency of all WT alleles is shown in grey. Mutant alleles individually exceeding 1% frequency in any generation were labelled as ‘confirmed r1 alleles’ (orange) or ‘r2 alleles’ (blue), all had been previously confirmed as r1 or r2. Mutations that were individually present at less than 1% frequency were grouped together as in-frame (light orange) or out-of-frame (light blue).

The rates of invasion observed here represent a significant improvement over the first generation gene drive (vas2-CRISPRh) targeted to the exact same target sequence (included for comparison in Fig 5A), where the spread of the drive was markedly slower and declined before it reached 80% frequency in the population [7].

Our population suppression gene drive is designed to exert a reproductive load on the population by targeting a gene that is essential for viable egg production. To investigate the magnitude of this load, we counted (from generation 4) the number of viable eggs produced each generation to measure the level of population suppression. Egg production was suppressed by an average of 92% (compared to maximal output of the cage) in each cage at or shortly after the peak in drive frequency, representing a reduction from more than 15,000 eggs to under 1,200 eggs (Fig 5A). Since we set a fixed carrying capacity for the adult population in the cage, selecting 600 larvae each generation, the reduction in egg output, although severe, was insufficient to suppress the population below this carrying capacity. In practice, in the wild, the effect of these levels of reproductive suppression will depend very much on the strength of density-dependent mortality that is occurring in the relevant mosquito larval habitats [33,34].

The creation and selection of resistant mutations is delayed in cage invasion experiments when using the zpg promoter

Both r1 mutations and r2 mutations can retard the invasiveness of a gene drive, yet r1 mutations are more problematic since they are likely to be strongly selected due to the relative positive fitness they confer by restoring function to the target gene.

To determine the rate of accumulation of these mutations during the invasion experiment we sequenced across the target locus in samples of pooled individuals from intermittent generations that spanned the rise and fall in frequency of the gene drive. We recorded the relative proportion of wild-type alleles and various r1 and r2 alleles among remaining non-drive alleles as the gene drive invaded the population over time (Fig 5B). For the zpg-CRISPRh constructs, which showed the biggest improvement in fecundity of carrier females (containing one drive allele and one wild-type allele) compared to previous constructs, resistance did not show obvious signs of selection (judged by large increases in frequency) until more than 90% of individuals were positive for the gene drive. In contrast, our previous data for the vas2-driven constructs showed that resistance was selected much earlier, being already present at high frequency in the 2nd generation when the frequency of drive-positive individuals was less than 70%. This is likely due to a combination of factors: the somatic leakiness of the vas2 promoter resulting in a significant fitness cost in carrier females and thus a relative fitness benefit to the r1 allele at a much earlier stage in the invasion, even when drive homozygotes are still rare; nuclease deposition from the vas2 promoter leading to a high initial frequency of r2 alleles, resulting in many individuals that are null (either homozygous for the r2 allele or contain one r2 allele and one drive allele) for the target gene therefore meaning that any non-null allele has a stronger relative fitness advantage.

Not only does the zpg promoter delay the onset of drive resistance, it also reduces the range of resistant alleles created (Fig 5B). In the 50% release cages, only 2 mutant alleles were detected above threshold frequency (>1% of non-drive alleles) both of which had been previously confirmed to be of the r1 class. By generation 8, one of the two had spread to more than 90% frequency yet the most abundant allele was reversed in the replicate cages–suggesting that selection for one or the other resistant mutations is stochastic and not because one is more effective at restoring fertility. The equivalent release of vas2-CRISPRh generated 9–12 mutant alleles above 1% frequency by generation 2 and this variance was maintained over time despite a strong stratification towards those of the r1 class [9]. This reduced complexity of alleles generated by zpg-CRISPRh may be related to the late onset of resistance, when the majority of alleles at the target locus are drive alleles meaning that there are very few ‘free’ alleles on which r1 alleles can be generated, resulting in the stochastic selection of just a few.

The very late onset of resistance–if it is to occur–is a feature, not immediately intuitive, of this type of gene drive whose goal is suppression and where heterozygous ‘carriers’ are intended to show minimal fitness costs. Selection for r1 alleles only really becomes strong when the gene drive is close to fixation; when most individuals have at least one copy of the gene drive the relative advantage of an r1 allele over remaining wild-type alleles (that have a high probability of being removed by homing of the gene drive allele) or the drive allele (with high probability of finding itself in a barren female, homozygous for the drive) is at its highest.

Incorporating experimental rates of resistance, embryonic end-joining and homology-directed repair into a population model

We extend previous models of homing-based gene drives [9,35,36], allowing the option of embryonic activity from paternally and maternally derived nuclease that can be resolved through end-joining–forming r1 and r2 alleles–or HDR. Using this model (see S1 Text) and the baseline parameter values from rates of fecundity and repair outcomes following germline and embryonic nuclease activity (S3 and S4 Tables) we generated the expected dynamics of spread and population egg output over the 16 generations of the experiment (Fig 6). For both 50% and 10% releases, the model captures the general trend of initial spread that is met by a significant suppression in egg output and an eventual recovery of the population as the gene drive is replaced by resistant mutations. Notably, the observed dynamics of spread and population suppression were faster than the deterministic prediction in all replicates. One possible explanation for this is the sensitivity of the model to the fertility of female zpg-CRISPRh heterozygotes and the extent to which fertility is restored by resistant R1 alleles (S2 Fig)–two parameters that are particularly difficult to measure precisely from our simple measurements of female fecundity and whose real values may be somewhat different in the inter-generational cage invasion experiment [7,9]. Interestingly, these parameters exert their effect upon drive dynamics in concert: improvements to heterozygous female fertility increase the rate of spread and peak in drive frequency, whereas an r1 allele that fails to restore full wild-type fertility retards the rate at which the drive is removed from the population. Alternatively, there may be extra sources of stochastic variation such as variation in distributions of egg number and degree of participation of females and males in mating not captured in the model.

Fig 6. Comparison of observed zpg-CRISPRh drive frequency and egg output data to deterministic and stochastic model predictions.

Fig 6

zpg-CRISPRh/+ individuals were released into replicate caged WT populations at 50% (left) or 10% (right) initial frequency of CRISPRh/+. The frequency of drive-modified mosquitoes (top panels) and the entire egg output per generation (bottom panels) were recorded. Observed data were compared to a deterministic, discrete-generation model (dashed line) based upon observed rates of fertility, homing, and resistance generated by end-joining in the germline and embryo (S1 Table). Grey lines show 20 stochastic simulations assuming that females may fail to mate, or mate once with a male of a given genotype according to its frequency in the male population; mated females produce eggs in amounts determined by sampling with replacement from experimental values that subsequently hatch according to the genotype of the mother; of the 600 larvae chosen randomly to populate next generation, some fail to survive to adulthood. Probabilities of mating, egg production, hatching and survival from larval stage to adult are estimated from experiment (S2 Table) and random numbers for these events drawn from the appropriate multinomial distributions. Model egg counts for each release are normalised such that the deterministic value corresponds to the average of the two replicate cage experiments at generation sixteen.

Conclusions

Building suppression gene drives for mosquito control that are fit for purpose requires a combination of the following features: optimal target sites that show high functional constraint; the targeting of multiple sites by the same gene drive construct; fine tuning of the expression of the nuclease that serves as the gene drive’s ‘motor’ in order that the drive shows the most efficient invasion dynamics. A number of these theorised improvements to design have been substantiated: multiplexing through the use of multiple guide RNAs in a single drive construct has been shown to improve robustness of a range of drive elements [13,21,37,38]; judicious choice of functionally constrained sites in essential genes has meant that gene drives targeting such sites do not generate resistant alleles that are selected, at least in the laboratory [8,37]. For the last aspect–optimising expression–we have shown here that simple changes to the promoter controlling nuclease activity can lead to drastic improvements in the speed of invasion due to two principal reasons: 1) less propensity to induce end-joining repair in the germline and 2) improved fecundity of ‘carrier’ females that contain a single copy of the gene drive and transmit it in a super-Mendelian fashion to their offspring.

The combined effect of the improvements conferred by the zpg promoter meant that a gene drive targeting a female fertility gene, at a site otherwise extremely prone to generate resistance [9], could still spread close to fixation while imposing a very strong reproductive load before resistant alleles eventually became selected.

The propensity for maternal and paternal deposition of the nuclease under control of the promoters of the drive constructs is an important variable that we have shown can vary greatly. There is also the possibility that both the end-joining/HDR ratio and the magnitude of parental effect might additionally be locus dependent to some extent [13,30]. Indeed, when the zpg promoter was used to control expression of a homing-based gene drive at the doublesex locus we noticed a paternal effect contributing to reduced fecundity that was not observed here [8]. Thus, we cannot exclude the possibility that local cross-talk with other nearby transcriptional enhancers or promoters, either endogenous to the genome or as part of additional elements of any gene drive construct, may affect its expression characteristics.

Our data on the relative contributions of end-joining repair and homology-directed repair in the germline and in the early embryo will be particularly important for the modelling of expected performance of gene drive constructs in mosquito populations, not only for suppressive drives but for so-called population replacement drives that also rely on CRISPR-based homing activity [6,39]. This data, coupled with the improvements to drive performance conferred by promoter choice, should help expedite the building of effective gene drives for mosquito control.

Methods

Ethics statement

All animal work was conducted according to UK Home Office Regulations and approved under Home Office License PPL 70/6453.

Amplification of promoter and terminator sequences

In determining the length of upstream region to take from each candidate gene to serve as a promoter we took a maximal region of 2kb upstream of the coding sequence, or the entire intergenic distance to the end of the coding sequence of the neighbouring gene, if shorter. The published Anopheles gambiae genome sequence provided in Vectorbase [39] was used as a reference to design primers in order to amplify the promoters and terminators of the three Anopheles gambiae genes: AGAP006098 (nanos), AGAP006241 (zero population growth) and AGAP007365 (exuperantia). Using the primers described in S5 Table we performed PCRs on 40 ng of genomic material extracted from wild-type mosquitoes of the G3 strain using the Wizard Genomic DNA purification kit (Promega). The primers were modified to contain suitable Gibson assembly overhangs (underlined) for subsequent vector assembly, and an XhoI restriction site upstream of the start codon. Promoter and terminator fragments were 2092 bp and 601 bp for nos, 1074 bp and 1034 bp for zpg, and 849 bp and 1173 bp for exu, respectively. The sequences of all regulatory fragments can be found in S6 Table.

Generation of CRISPRh drive constructs

We modified available template plasmids used previously in Hammond et al. (2016) to replace and test alternative promoters and terminators for expressing the Cas9 protein in the germline of the mosquito. p16501, which was used in that study carried a human-optimised Cas9 (hCas9) under the control of the vas2 promoter and terminator, an RFP cassette under the control of the neuronal 3xP3 promoter and a U6:sgRNA cassette targeting the AGAP007280 gene in Anopheles gambiae.

The hCas9 fragment and backbone (sequence containing 3xP3::RFP and a U6::gRNA cassette), were excised from plasmid p16501 using the restriction enzymes XhoI+PacI and AscI+AgeI respectively. Gel electrophoresis fragments were then re-assembled with PCR amplified promoter and terminator sequences of zpg, nos or exu by Gibson assembly to create new CRISPRh vectors named p17301 (nos), p17401 (zpg) and p17501 (exu).

Integration of gene drive constructs at the AGAP007280 locus

CRISPRh constructs containing Cas9 under control of the zpg, nos and exu promoters were inserted into an hdrGFP docking site previously generated at the target site in AGAP007280 (Hammond et al., 2016). Briefly, Anopheles gambiae mosquitoes of the hdrGFP-7280 strain were reared under standard conditions of 80% relative humidity and 28°C, and freshly laid embryos used for microinjections as described before [40]. Recombinase-mediated cassette exchange (RMCE) reactions were performed by injecting each of the new CRISPRh constructs into embryos of the hdrGFP docking line that was previously generated at the target site in AGAP007280 [7]. For each construct, embryos were injected with solution containing CRISPRh (400ng/μl) and a vas2::integrase helper plasmid (400ng/μl) [41]. Surviving G0 larvae were crossed to wild type and transformants were identified by a change from GFP (present in the hdrGFP docking site) to DsRed linked to the CRISPRh construct that should indicate successful RMCE.

Phenotypic assays to measure fertility and rates of homing

Heterozygous CRISPRh/+ mosquitoes from each of the three new lines zpg-CRISPRh, nos-CRISPRh, exu-CRISPRh, were mated to an equal number of wild-type mosquitoes for 5 days in reciprocal male and female crosses. Females were blood fed on anesthetized mice on the sixth day and after 3 days, a minimum of 40 were allowed to lay individually into a 25-ml cup filled with water and lined with filter paper. The entire larval progeny of each individual was counted and a minimum of 50 larvae were screened to determine the frequency of the DsRed that is linked to the CRISPRh allele by using a Nikon inverted fluorescence microscope (Eclipse TE200). When testing each line, age matched wild-type mosquitoes were included as comparators to control for variability in bloodmeal batch/insectary conditions that can affect clutch size. Females that failed to give progeny and had no evidence of sperm in their spermathecae were excluded from the analysis. Statistical differences between genotypes were assessed using the Kruskal-Wallis and Mann-Whitney tests, performed using GraphPad Prism version 8.4.3 (471) for Mac, GraphPad Software, San Diego, California USA, www.graphpad.com. The entirety of the raw data including full list of test statistics and sample sizes, as well all raw experimental data points, are included in S1 Data as an Excel file with the data tabulated according to the experimental figure in which it was included.

Caged population invasion experiments

The cage trials were performed following the same principle described before in Hammond et al. (2016). Briefly, heterozygous zpg-CRISPRh that had inherited the drive from a female parent were mixed with age-matched wild type at L1 at 10% or 50% frequency of heterozygotes. At the pupal stage, 600 were selected to initiate replicate cages for each initial release frequency. Adult mosquitoes were left to mate for 5 days before they were blood fed on anesthetized mice. Two days after, the mosquitoes were left to lay in a 300ml egg bowl filled with water and lined with filter paper. Each generation, all eggs were allowed two days to hatch and 600 randomly selected larvae were screened to determine the transgenic rate by presence of DsRed and then used to seed the next generation. From generation 4 onwards, adults were blood-fed a second time and the entire egg output photographed and counted using JMicroVision V1.27. Larvae were reared in 2L trays in 500 ml of water, allowing a density of 200 larvae per tray. After recovering progeny, the entire adult population was collected and entire samples from generations 0, 2, 4, 5, 6, 7, 8 and 12 (50% release) and 0, 2, 5, 8, 9, 10, 11, 12 and 15 (10% release) were used for pooled amplicon sequence analysis.

Pooled amplicon sequencing

Pooled amplicon sequencing was performed essentially as described before in Hammond et al. (2017). Genomic DNA was mass extracted from pooled samples of mosquitoes using the Wizard Genomic DNA purification kit (Promega), and 90 ng of each used for PCR using KAPA HiFi HotStart Ready Mix PCR kit (Kapa Biosystems) in 50 ul reactions. For caged experiment generations 0, 2, 5 & 8, a 332-bp locus spanning the target site was amplified using primers designed to include the Illumina Nextera Transposase Adapters (underlined), 7280-Illumina-F (TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGGAGAAGGTAAATGCGCCAC) and 7280-Illumina-R (GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGCGCTTCTACACTCGCTTCT). For caged experiment generations 4, 6, 7 and 12 of the 50% release; and 9, 10, 11, 12 and 15 of the 10% release, a 196-bp locus spanning the target site was amplified using primers designed to include Illumina partial adapters (underlined), Illumina-AmpEZ-7280-F1 (ACACTCTTTCCCTACACGACGCTCTTCCGATCTCGTTAACTGTCTTGGTGGTGAGG) and Illumina-AmpEZ-7280-R1 (GACTGGAGTTCAGACGTGTGCTCTTCCGATCTCACGCTTAACGTCGTCGTTTC). For deposition testing, a 200-bp locus spanning the target site was amplified using primers designed to include Illumina partial adapters (underlined), Illumina-AmpEZ-7280-F2 (ACACTCTTTCCCTACACGACGCTCTTCCGATCTCGGGCAAGAAGTGTAACGG) and Illumina-AmpEZ-7280-R2 (TGGAGTTCAGACGTGTGCTCTTCCGATCTGTCGTTTCTTCCGATGTGAAC). PCR reactions were amplified for 20 cycles and subsequently processed and sequenced using an Illumina MiSeq instrument (Genewiz).

Analysis of pooled amplicon sequencing

Pooled amplicon sequencing reads were analysed using CRISPResso software v1.0.8 [42] using an average read quality threshold of 30. Insertions and deletions were included if they altered a window of 20 bp surrounding the cleavage site that was chosen on the basis of previously observed mutations at this locus [9]. Allele frequencies were calculated by summing individual insertion or deletion events across all haplotypes on which they were found. A large insertion event, representing incomplete homing of CRISPRh, was found to occur outside of this window and its combined frequency across several haplotypes was calculated and included in the final frequency tables.

Deposition testing

F1 heterozygotes containing a gene drive and resistant allele (GD/r1) were generated by crossing zpg-CRISPRh, nos-CRISPRh or vas2-CRISPRh to a resistant strain that is homozygous for the 203-GAGGAG r1 allele at the target site in AGAP007280. This scheme allowed the testing of all gene drive constructs, including those (e.g. vas2-CRISPRh) that would otherwise cause high levels of female sterility when balanced against a wild-type allele. An average of 40 F1 heterozygotes were group mated to an excess of wild type in reciprocal male and female crosses, and allowed to lay en masse. F2 progeny were screened for the absence of DsRed that is linked to the CRISPRh allele and pooled together for mass genomic DNA extraction and pooled amplicon sequencing as described elsewhere. A minimum of 118 F2 individuals were interrogated for each condition. The summary data for amplicon sequencing experiments reported for Fig 3 (testing of deposited nuclease activity) is available in S2 Data.

Estimation of meiotic end-joining

A minimum of 200 male or 500 female zpg-CRISPRh drive heterozygotes (F0) were crossed to a line (‘docking line’) heterozygous for a GFP+ marked knock-out AGAP007280 allele and allowed to lay eggs. Upon egg-hatching, L1 larvae were sorted using COPAS (complex object parametric analyser and sorter), as in Marois et al. [43]. The very rare fraction of progeny (F1) that inherited the GFP+ marked knockout but not the zpg-CRISPRh allele due to lack of homing, were isolated from the progeny pool. They were grown to adulthood and their gDNA was individually extracted using either the Wizard Genomic DNA purification kit (Promega) or the DNeasy Blood & Tissue Kit (Qiagen). A 1048-bp region spanning the gene drive target site was amplified using primers Seq-7280-F (GCACAAATCCGATCGTGACA) and Seq-7280-R3 (GGCTTCCAGTGGCAGTTCCGTA) and Sanger-sequenced using primer Seq-7280-F5 (CGTTTGTGTGTCAGAGCAAGTCG), so that only the allele that was exposed to prior nuclease activity meiotically would amplify (and not the GFP+ allele). In total, 218 F1 progeny descended from female zpg-CRISPRh heterozygote and 239 F1 progeny descended from male zpg-CRISPRh heterozygote were analysed.

Supporting information

S1 Fig. Cleavage by CRISPRh can generate resistant mutations as a by-product of error-prone end-joining.

After cleavage by the nuclease, the majority of target sites will be repaired by homology-directed repair (HDR), leading to a copying over of the CRISPRh allele called homing. A small fraction of targets may remain unmodified or may repair perfectly, resulting in a target that can be cleaved upon re-exposure by the nuclease. Chromosomes that are repaired by end-joining may generate a mutant target site that can no longer be cleaved by the nuclease. If the target site is essential (i.e. a female fertility gene), then a mutation that disrupts the function of the target gene, called an r2 mutation, will be selected out of the population. Mutations that re-code a functional target gene, called an r1 mutation, are resistant to the gene drive and will come under strong selection in presence of the drive.

(TIF)

S2 Fig. Comparison of cage data with deterministic model results incorporating percentage change in parameter estimates.

(A) Increasing the fertility of heterozygous zpg-CRISPRh females by up to 80% can accurately predict the experimental data, suggesting the fertility assays underestimate their true fecundity. Note that for (A), W/D female fertilities with maternal/paternal parental effects are varied together, keeping their ratio constant. (B) A small increase in the homing rates of both males and females can have a dramatic effect on the spread of the gene drive during the early generations. By increasing the homing rate estimates of males, similar to that of females, the improved rate of spread better resembles experimental observation. (C) The resilience of the gene drive within the populations increases when the fertility of females with at least one resistant functional allele (r1) is reduced. The reduced output in progeny of these females slows the spread of r1 alleles and thus, allows the drive to spread closer to fixation and to exert a longer lasting and stronger reproductive load on the population. These modelling data suggest that small cage experiments and phenotypic assays provide crude estimates of fertility and drive, and thus both modelling and large-cage testing are needed to better capture and estimate strain performance.

(TIF)

S3 Fig. Depletion of wild-type target site alleles and formation of mutations caused by parentally deposited nuclease from different gene drive constructs.

zpg-CRISPRh (‘Zpg’), nos-CRISPRh (‘Nos’)or vas2-CRISPRh (‘Vas’) were crossed to a resistant strain (homozygous for the r1 allele 203-GAGGAG) to generate F1 heterozygotes containing both a gene drive and resistant allele (GD/r1). F1 heterozygote males (M) and females (F) and r1/r1 homozygote females (control) were crossed to wild type and their non-drive F2 progeny analysed by pooled amplicon sequencing across the target site in AGAP007280. (A) Amplicon sequencing results from F2 individuals with genotype WT/r1 (left) and their F3 progeny derived from the F2 crossed to WT (right) are plotted to show the fraction of novel resistant (“R”) alleles (‘Proportion of novel R’, top). (B) Amplicon sequencing results from F2 individuals with genotype WT/r1 (left) and their F3 progeny derived from the F2 crossed to WT (right) are plotted to show the fraction of WT alleles (‘Depletion of WT ‘, middle). Frequencies expected by Mendelian inheritance of the WT allele are indicated (dashed line). Deposited nuclease significantly depleted WT and generated novel R for nos-CRISPRh and vas2-CRISPRh females in the F2, but not zpg-CRISPRh females, or males of any class (Ordinary one-way ANOVA with Dunnett's multiple comparisons test, ****: p < 0.0001, ***: p < 0.001, *: p < 0.05, ns: non-significant). (C) Rates of embryonic EJ were estimated based upon the relative frequencies of novel R alleles in the F2 (left) and F3 (right). F2 estimates were calculated from the frequency of novel R alleles amongst the sum of WT and novel R (left). F3 estimates were calculated by multiplying the frequency of novel R by 4, the dilution factor expected due to additional WT alleles received from the parents (right). A minimum of 128 individuals were sequenced for each condition in the F2 and F3 generations and the number of founder F1 individuals is indicated (n). A summary of this data is shown in Fig 3B and 3C.

(TIF)

S1 Data. Raw Data for Figs 26 Excel file, tabulated according to figure.

Includes all raw data points, lists of test statistics and sample sizes.

(XLSX)

S2 Data. Summary data for amplicon sequencing experiments reported for Fig 3 (testing of deposited nuclease activity).

(XLSX)

S1 Text. Supplementary Methods describing the mathematical modelling in detail.

(DOCX)

S1 Table. Model parameters for zpg-CRISPRh.

(DOCX)

S2 Table. Additional parameters for stochastic model for zpg-CRISPRh.

(DOCX)

S3 Table. Primers used in this study to assemble the transformation vectors.

(DOCX)

S4 Table. Promoter and terminator sequences used in gene drive constructs.

(DOCX)

S5 Table. The proportions of germline stem cells of different genotypes arising from paternal effects.

(DOCX)

S6 Table. Genotype fitnesses and the proportion of each type of gamete produced by each genotype.

(DOCX)

Data Availability

All raw data used for the assembly of all figures is included as supplementary excel files. Raw sequencing reads (amplicon sequencing) from experiments described in this project is deposited at the European Nucleotide Archive under Project ID: PRJEB37873.

Funding Statement

This work was supported by grants from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Bhatt S., Weiss D.J., Cameron E., Bisanzio D., Mappin B., Dalrymple U., et al. 2015. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature 526(7572), 207–211. 10.1038/nature15535 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.World Health Organisation. 2017 Vector-borne diseases. (Geneva.
  • 3.Burt A. 2003. Site-specific selfish genes as tools for the control and genetic engineering of natural populations. Proc Biol Sci 270(1518), 921–928. 10.1098/rspb.2002.2319 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Esvelt K.M., Smidler A.L., Catteruccia F., Church G.M. 2014. Concerning RNA-guided gene drives for the alteration of wild populations. eLife 3, e03401 10.7554/eLife.03401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gantz V.M., Bier E. 2015. Genome editing. The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations. Science 348(6233), 442–444. 10.1126/science.aaa5945 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Gantz V.M., Jasinskiene N., Tatarenkova O., Fazekas A., Macias V.M., Bier E., et al. 2015. Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi. Proc Natl Acad Sci U S A 112(49), E6736–6743. 10.1073/pnas.1521077112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hammond A., Galizi R., Kyrou K., Simoni A., Siniscalchi C., Katsanos D., et al. 2016. A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae. Nat Biotechnol 34(1), 78–83. 10.1038/nbt.3439 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kyrou K., Hammond A.M., Galizi R., Kranjc N., Burt A., Beaghton A.K., et al. 2018. A CRISPR-Cas9 gene drive targeting doublesex causes complete population suppression in caged Anopheles gambiae mosquitoes. Nat Biotechnol 36(11), 1062–1066. 10.1038/nbt.4245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hammond A.M., Kyrou K., Bruttini M., North A., Galizi R., Karlsson X., et al. 2017. The creation and selection of mutations resistant to a gene drive over multiple generations in the malaria mosquito. PLoS Genet 13(10), e1007039 10.1371/journal.pgen.1007039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Champer J., Reeves R., Oh S.Y., Liu C., Liu J., Clark A.G., et al. 2017. Novel CRISPR/Cas9 gene drive constructs reveal insights into mechanisms of resistance allele formation and drive efficiency in genetically diverse populations. PLoS Genet 13(7), e1006796 10.1371/journal.pgen.1006796 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Marshall J.M., Buchman A., Sanchez C.H., Akbari O.S. 2017. Overcoming evolved resistance to population-suppressing homing-based gene drives. Sci Rep 7(1), 3776 10.1038/s41598-017-02744-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Champer S.E., Oh S.Y., Liu C., Wen Z., Clark A.G., Messer P.W., et al. 2020 Computational and experimental performance of CRISPR homing gene drive strategies with multiplexed gRNAs. Sci Adv 6(10), eaaz0525 10.1126/sciadv.aaz0525 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Champer J., Liu J., Oh S.Y., Reeves R., Luthra A., Oakes N., et al. 2018. Reducing resistance allele formation in CRISPR gene drive. Proceedings of the National Academy of Sciences 115(21), 5522–5527. 10.1073/pnas.1720354115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Baker D.A., Nolan T., Fischer B., Pinder A., Crisanti A., Russell S. 2011. A comprehensive gene expression atlas of sex- and tissue-specificity in the malaria vector, Anopheles gambiae. BMC Genomics 12, 296 10.1186/1471-2164-12-296 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Tazuke S.I., Schulz C., Gilboa L., Fogarty M., Mahowald A.P., Guichet A., et al. 2002. A germline-specific gap junction protein required for survival of differentiating early germ cells. Development 129(10), 2529–2539. [DOI] [PubMed] [Google Scholar]
  • 16.Magnusson K., Mendes A.M., Windbichler N., Papathanos P.A., Nolan T., Dottorini T., et al. 2011. Transcription regulation of sex-biased genes during ontogeny in the malaria vector Anopheles gambiae. PLoS One 6(6), e21572 10.1371/journal.pone.0021572 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Berleth T., Burri M., Thoma G., Bopp D., Richstein S., Frigerio G., et al. 1988. The role of localization of bicoid RNA in organizing the anterior pattern of the Drosophila embryo. EMBO J 7(6), 1749–1756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Schupbach T., Wieschaus E. 1986. Germline autonomy of maternal-effect mutations altering the embryonic body pattern of Drosophila. Dev Biol 113(2), 443–448. 10.1016/0012-1606(86)90179-x [DOI] [PubMed] [Google Scholar]
  • 19.Wang C., Lehmann R. 1991. Nanos is the localized posterior determinant in Drosophila. Cell 66(4), 637–647. 10.1016/0092-8674(91)90110-k [DOI] [PubMed] [Google Scholar]
  • 20.Rangan P., DeGennaro M., Jaime-Bustamante K., Coux R.X., Martinho R.G., Lehmann R. 2009. Temporal and spatial control of germ-plasm RNAs. Curr Biol 19(1), 72–77. 10.1016/j.cub.2008.11.066 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kandul N.P., Liu J., Buchman A., Gantz V.M., Bier E., Akbari O.S. 2020. Assessment of a Split Homing Based Gene Drive for Efficient Knockout of Multiple Genes. G3 (Bethesda) 10(2), 827–837. 10.1534/g3.119.400985 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Akbari O.S., Papathanos P.A., Sandler J.E., Kennedy K., Hay B.A. 2014. Identification of germline transcriptional regulatory elements in Aedes aegypti. Sci Rep 4, 3954 10.1038/srep03954 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Li M., Yang T., Kandul N.P., Bui M., Gamez S., Raban R., et al. 2020. Development of a confinable gene drive system in the human disease vector Aedes aegypti. Elife 9 10.7554/eLife.51701 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Adelman Z.N., Jasinskiene N., Onal S., Juhn J., Ashikyan A., Salampessy M., et al. 2007. nanos gene control DNA mediates developmentally regulated transposition in the yellow fever mosquito Aedes aegypti. Proc Natl Acad Sci U S A 104(24), 9970–9975. 10.1073/pnas.0701515104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Macias V.M., Jimenez A.J., Burini-Kojin B., Pledger D., Jasinskiene N., Phong C.H., et al. 2017. nanos-Driven expression of piggyBac transposase induces mobilization of a synthetic autonomous transposon in the malaria vector mosquito, Anopheles stephensi. Insect Biochem Mol Biol 87, 81–89. 10.1016/j.ibmb.2017.06.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Meredith J.M., Underhill A., McArthur C.C., Eggleston P. 2013. Next-generation site-directed transgenesis in the malaria vector mosquito Anopheles gambiae: self-docking strains expressing germline-specific phiC31 integrase. PLoS One 8(3), e59264 10.1371/journal.pone.0059264 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Hong C.C., Hashimoto C. 1995. An unusual mosaic protein with a protease domain, encoded by the nudel gene, is involved in defining embryonic dorsoventral polarity in Drosophila. Cell 82(5), 785–794. 10.1016/0092-8674(95)90475-1 [DOI] [PubMed] [Google Scholar]
  • 28.LeMosy E.K., Hashimoto C. 2000. The nudel protease of Drosophila is required for eggshell biogenesis in addition to embryonic patterning. Dev Biol 217(2), 352–361. 10.1006/dbio.1999.9562 [DOI] [PubMed] [Google Scholar]
  • 29.Galizi R., Hammond A., Kyrou K., Taxiarchi C., Bernardini F., O'Loughlin S.M., et al. 2016. A CRISPR-Cas9 sex-ratio distortion system for genetic control. Sci Rep 6, 31139 10.1038/srep31139 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Champer J., Chung J., Lee Y.L., Liu C., Yang E., Wen Z., et al. 2019. Molecular safeguarding of CRISPR gene drive experiments. Elife 8 10.7554/eLife.41439 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Guichard A., Haque T., Bobik M., Xu X.S., Klanseck C., Kushwah R.B.S., et al. 2019. Efficient allelic-drive in Drosophila. Nat Commun 10(1), 1640 10.1038/s41467-019-09694-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.KaramiNejadRanjbar M., Eckermann K.N., Ahmed H.M.M., Sanchez C.H., Dippel S., Marshall J.M., et al. 2018. Consequences of resistance evolution in a Cas9-based sex conversion-suppression gene drive for insect pest management. Proc Natl Acad Sci U S A 115(24), 6189–6194. 10.1073/pnas.1713825115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Deredec A., Godfray H.C., Burt A. 2011. Requirements for effective malaria control with homing endonuclease genes. Proc Natl Acad Sci U S A 108(43), E874–880. 10.1073/pnas.1110717108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Legros M., Lloyd A.L., Huang Y., Gould F. 2009. Density-dependent intraspecific competition in the larval stage of Aedes aegypti (Diptera: Culicidae): revisiting the current paradigm. J Med Entomol 46(3), 409–419. 10.1603/033.046.0301 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Beaghton A.K., Hammond A., Nolan T., Crisanti A., Burt A. 2019. Gene drive for population genetic control: non-functional resistance and parental effects. Proc Biol Sci 286(1914), 20191586 10.1098/rspb.2019.1586 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Deredec A., Burt A., Godfray H.C. 2008. The population genetics of using homing endonuclease genes in vector and pest management. Genetics 179(4), 2013–2026. 10.1534/genetics.108.089037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Oberhofer G., Ivy T., Hay B.A. 2019. Cleave and Rescue, a novel selfish genetic element and general strategy for gene drive. Proc Natl Acad Sci U S A 116(13), 6250–6259. 10.1073/pnas.1816928116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Champer J., Yang E., Lee E., Liu J., Clark A.G., Messer P.W. 2020. A CRISPR homing gene drive targeting a haplolethal gene removes resistance alleles and successfully spreads through a cage population. Proc Natl Acad Sci U S A 117(39), 24377–24383. 10.1073/pnas.2004373117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Pham T.B., Phong C.H., Bennett J.B., Hwang K., Jasinskiene N., Parker K., et al. 2019. Experimental population modification of the malaria vector mosquito, Anopheles stephensi. PLoS Genet 15(12), e1008440 10.1371/journal.pgen.1008440 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Giraldo-Calderon G.I., Emrich S.J., MacCallum R.M., Maslen G., Dialynas E., Topalis P., et al. 2015. VectorBase: an updated bioinformatics resource for invertebrate vectors and other organisms related with human diseases. Nucleic Acids Res 10.1093/nar/gku1117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Fuchs S., Nolan T., Crisanti A. 2013. Mosquito transgenic technologies to reduce Plasmodium transmission. Methods Mol Biol 923, 601–622. 10.1007/978-1-62703-026-7_41 [DOI] [PubMed] [Google Scholar]
  • 42.Pinello L., Canver M.C., Hoban M.D., Orkin S.H., Kohn D.B., Bauer D.E., et al. 2016. Analyzing CRISPR genome-editing experiments with CRISPResso. Nat Biotechnol 34(7), 695–697. 10.1038/nbt.3583 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Volohonsky G., Terenzi O., Soichot J., Naujoks D.A., Nolan T., Windbichler N., et al. 2015. Tools for Anopheles gambiae Transgenesis. G3 (Bethesda) 5(6), 1151–1163. 10.1534/g3.115.016808 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Gregory S Barsh, Owain Rhys Edwards

2 Oct 2020

* Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. *

Dear Dr Nolan,

Thank you very much for submitting your Research Article entitled 'Regulating the expression of gene drives is key to increasing their invasive potential and the mitigation of resistance' to PLOS Genetics. Your manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important topic but identified some aspects of the manuscript that should be improved.

We therefore ask you to modify the manuscript according to the review recommendations before we can consider your manuscript for acceptance. Your revisions should address the specific points made by each reviewer.

In addition we ask that you:

1) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our archive. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Owain Rhys Edwards, Ph.D.

Guest Editor

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: Gene drive is being used for population modification (replacement/alteration) and population suppression. Much recent success revolves around the use of Cas9 to site-specifically cleave one or more target sites, with the outcome of repair following cleavage then determining, depending on the system, whether drive occurs or not. In all Cas9-based drive systems (other than underdominance) germline cleavage is required. Most of the promoters used to drive expression in the germline have effects on other life stages, either through maternal carryover-dependent cleavage of the paternal chromosome in somatic cells, and/or through cleavage in somatic cells due to a non-germline component of gene expression. For those of us working on purely cleavage-based mechanisms of Cas9-mediated drive such as clvr, expression at other stages is generally not problematic. In fact maternal carryover-dependent cleavage makes drive stronger. However, in the context of homing, particularly population suppression, maternal carryover and expression in somatic cells can be devastating for several reasons. First, since the early embryo lacks G1 and G2 cycles (at least in Drosophila there is only S and M for the first 12 divisions), there is no possibility of repair by HR. This leads to a high frequency of repair by NHEJ, which can create resistant alleles. Second, cleavage in the zygote makes individuals heterozygous for the HEG unfit. The HEG insertion disrupts one allele of the essential gene targeted. In the absence of carryover or somatic expression these individuals are fit since the genes being targeted are haplosufficient. However, when carryover or somatic expression disrupts the second allele, heterozygotes now suffer a fitness cost due to being homozygous loss of function (LOF) in many cells. this can slow or stop drive.

This group has addressed many of these issues by targeting a female-splice form of the doublesex (dsx) gene, which apparently cannot (thus far) mutate to a functional but uncleavable (resistant) form. This solves the problem of carryover-dependent NHEJ. They have also identified a germline promoter, from the zpg gene, that has minimal (though not completely absent) maternal carryover, limiting the fitness costs to heterozygotes. Work describing the use of this promoter (and the associated HEG) to bring about complete population elimination has been described in two recent papers, Kyrou et al., 2018, and Simoni et al., 2020.

What has not been reported is a careful description of how the authors characterized zpg-HEGs and those of earlier generations, which fared less well, exactly how non-optimal characteristics can lead to failure, and how (quantitatively) constructs that avoid these pitfalls do so. These details are critical as they inform the field about how drives can and will fail, and how to characterize them so as to understand where and when this will occur. Thus, while this manuscript comes after reports of dramatic success in bringing about suppression, it is a very important work in its own right. It provides a careful blueprint for understanding how a HEG should be characterized: how to "look under the hood" using genetics and sequencing to determine exactly what is going on with the parts that make up the HEG.

The strategy taken is interesting, and involves targeting a gene, nudel in Drosophila, required for female fertility. The authors had previously targeted this gene only to have resistant alleles arise rapidly (earlier publications). They target it again here precisely because it fails, and thus the rate of failure and how failure occurs can provide insight into how to avoid it (dsx, because it always works does not provide this opportunity). HEGs were constructed that target nudel, with Cas9 being driven by one of three different germline promoters, zpg, nos and exu. Data from the earlier published experiments using the vasa promoter served as a benchmark for improvements.

Overall the experiments are very clear and the data convincing. The use of marked chromosomes to follow the generation and fate of alleles over multiple generations is really a tour de force of population genetic characterization of an evolving system, particularly in a non-model system. The conclusions are clear and provide a clear roadmap for others in terms of how to characterize HEG behavior. This work will become and set the standard for all work going forward– which is a good thing.

I have a series of comments below, but all of these are questions or comments asking for further clarification of some discussion or figures.

1. One thing I am unclear on in Fig. 2CEGI is what the marks are in the top row of each plot. I am guessing these may be fecundity plots for wildtype females crossed to wildtype males, since then the statistical significance numbers make sense. This is suggested by the WT symbol on the far left, but, it is not indicated explicitly in the figure legend.

Also, throughout the figures, including Fig. 2, the type used is very thin and not bolded. it would help a lot if all type and male and female symbols were bolded and in some cases perhaps made larger. There is plenty of space in the figure. The same goes for the schematic presented in panel A. All parts could be larger and more clear. The authors might also consider expanding the schematic a bit to try and capture some of the problems (resistance alleles, carryover) that are the topic of the figure. it takes a bit of thinking to understand the significance of the fact that they are not just looking at progeny of heterozygotes, but progeny of heterozygotes that came from a specific sex. This would be a nice place to illustrate the things that go wrong and how they depend on grandparents. This has not really been presented schematically before, I think. Finally, panel A does not seem to be noted in the legend.

2. The paragraph lines 222-233 is a central part of the story. it would be useful to expand some of the single sentences into a few sentences to explain the results. For example, what is the thinking on the reduced fecundity of nos-expressing males. Is this likely to be male carryover, or is it just that perhaps the expression of Cas9 in males in the nos expression pattern is a bit toxic somehow to sperm? It would also be useful to unpack a little bit the key sentence that describes the zpg results, in terms of what it tells us.

"For zpg-CRISPRh we observed no reduction in male fecundity and the reduction in female fecundity was not subject to any maternal effect, consistent with the absence of maternal effect on homing for the same construct".

3. Figure 3 describes a truly elegant experiment designed to look at the effects of parental nuclease deposition, by following the fate of an existing R1 allele when in trans to a wildtype allele, and in the presence of Cas9 provided by one parental gamete type or the other through deep sequencing. This experiment also allows them to look for the appearance of new alleles due to Cas9 deposition..

The left panel, which schematizes the experiment, could be made much bigger and more bold. Also the colors for the different alleles are a bit too similar. it would be useful to make them more different and have a legend in the figure itself that makes clear which is which.

In the legend in part A there is no discussion of the F3 generation.

4. In Figure 4 the authors look at the what happens when homing does not occur. Are new alleles created, and if so what are they? There are a couple of things I am unclear about. First, in the cross scheme they have GD/DL twice in the F2, at 47%. Should one of these be GD/WT? Also, they do not explain in the text or the legend the significance of the docking line. Is this just an insertion at the target site that eliminates the target site and provides a molecular difference easily scored by sequencing and/or visually? In short, it would be useful to explain the screen a bit more. The text is a bit telegraphic as to what is being tested and how. Since this is an online journal I do not think there are strict length limits that require minimal descriptions.

Finally, it is interesting that most of the alleles rated in the female germline are R1. Is there something to speculate on here? Is it just that this specific site tends to mutate in a way that creates a specific R1, or might something else be going on?

5. In Figure 5 the authors report on the behavior of the zpg drive targeting nudel. We know it is going to fail, but the question is, given what has been demonstrated in the earlier figures, how much better will it behave, and what do the alleles that stop it look like.

First, it represents a lot of work to show when and what the resistance alleles look like, at many different time points. This figure stands alone in the gene drive field in this respect.

The authors discuss the egg counts in panel A, but dont refer back to a specific figure panel as showing this.

In panel B it would be useful to explicitly label which experiment is which since there are six panels with two Y axes labels (which is hard to see because they are so small).

it is unclear from their discussion of panel B what the data in the two sets of Y axes panels tells us, because they re not referred to. It is not that clear from the discussion what we take away from the figures versus the discussion, which focuses mostly on the number of mutant alleles that arise and how these are lower with zpg.

6. I also have a question that arises from the authors discussion. In the beginning of this section they say that "For the zpg-CRISPRh constructs, which have minimal fitness costs on fecundity in carrier females (containing one drive allele and one wild type allele), resistance did not show obvious signs of selection"

and then later on in the same section they say "The very late onset of resistance - if it is to occur - is a feature, not immediately intuitive, of this type of gene drive whose goal is suppression and where heterozygous ‘carriers’ are intended to show minimal fitness costs. Selection for r1 alleles only really becomes strong when the gene drive is close to fixation - when most individuals have at least one copy of the gene drive the relative advantage of an r1 allele over remaining WT alleles (that have a high probability of being removed by homing of the gene drive"

I appreciate what they are trying to say in the second paragraph. A key feature of a suppression HEG is that so long as heterozygotes are mating with wildtypes no costs are incurred–for an IDEAL HEG. However, in the earlier data, Fig. 2, they show that zpg females suffer a 50% fecundity cost. While this is much lower than the costs associated with vasa, I think most people would still consider a 50% fecundity cost to be quite large. It would be useful to rethink the wording for the first statement, and link these costs to the second statement. While in ideal world this is how a HEG should behave, how does a 50% fecundity cost alter this calculation. Also, is it correct to say that resistance evolves late, or just that it manifests its effects late in the drive process, at least when only ideal HEG behavior is considered.

In short, it might be useful to reframe this section a bit, taking into account the fecundity costs, when R1 alleles arise, etc. I appreciate that the end result is clear in terms of increased drive persistence, but the arguments for how the observed behavior gets us there might be more clear. Again, I dont see space as a limitation.

7. In figure 6, panel lower left, it looks like the blue line goes to zero and then undergoes a dramatic increase. Can you explain?

Also, it looks like the data points are collected every other generation, 2-4-6. In this context the three tick marks between each set of numbers are a bit confusing and could be eliminated (since they cannot mean anything biological).

8. In the conclusions they say

"Indeed when the zpg promoter was used to control expression of a homing based gene drive at the doublesex locus we noticed a paternal effect contributing to reduced fecundity that was not observed here [8]" Can the authors expand for a sentence or two on how this is likely to occur: cas9 expression having effects on sperm fitness or paternal carryover? or something else. It would just be good to have a clear understanding of possible sources, since even some non-homing clvr-type drives proposed for suppression require germline only effects, and Cas9 is generally considered not to show paternal carryover (though most researchers do not look carefully for it).

////////////////////////

Very minor points.

1. We tracked the generation and selection of resistant mutations the course of a gene

It looks like the authors missed a word, perhaps "over" the course"

2. onset of target site resistance. Our results show that regulation of its expression

Maybe just change the word it to nuclease, to make clear what is being referred to

3. developing a robust gene drive.

...for homing based suppression

4. throughout the text the authors use the standard error of the mean, rather than standard deviation. This is just my personal opinion, but I find SEM values completely useless. It actually hides the diversity of outcomes that would be apparent on simple visual inspection of the data (like in figure 2). I like SD because it actually tells you something about the distribution. But, its just a suggestion.

5. In the methods zpg-crispr is listed twice at line 488

6. is this the docking line referred to in the text? If so it would be useful to expand a bit in the text as to the gfp-based method used here to identify these individuals.

"500 female zpg-CRISPRh drive heterozygotes (F0) were crossed to a line heterozygous for a GFP+ marked knock-out AGAP007280 allele and allowed to lay eggs. Upon egg hatching, L1 larvae were sorted using COPAS (complex object parametric analyser and sorter), as in Marois et al. (2012). The very rare fraction of progeny (F1) that inherited the GFP+ marked knockout but not the zpg-CRISPRh allele due to lack of homing..."

7. The authors refer to references 15 and 20 for data showing that zpg RNA is localized.

Line 123 " deposited nos and zpg mRNA concentrate at the germ plasm due to regulatory signals present on the untranslated regions, which also further restrict translation of maternal mRNAs to the germline [15, 20]." I have looked at these references and do not see any evidence that zpg mRNA is localized to germ plasm. Is this correct? it is of course for nanos, but I am not familiar with any localization data for zpg, particularly since it acts much earlier during oogenesis.

8. In supplement figure 2 legend the authors state that " (A) Increasing the fertility of heterozygous zpg-CRISPRh females by up to 80% can accurately predict the experimental data, suggesting the fertility assays underestimate their true fecundity."

Can they explain this a bit more and relate it to the data presented in Figure 2 on fecundity" What exactly do they mean here and how does it relate to Figure 2? More generally, should some or all of these observations be moved to the main text given that they seem to offer a set of discussion points (in the legend) that are distinct from those made in the text regarding how one should think about the data presented in the text. In short, it is confusing to present data in the text and then say in the supplement we get a better fit when we increase fecundity over what is obsrved, therefore the data in the text must not accurately reflect the real situation.

9. In supplementary Figure 4 it is not clear what the green highlights of specific bases mean. Are these sequence polymorphisms from the reference genome, or something else?

Reviewer #2: The manuscript "Regulating the expression of gene drives is key to increasing their invasive potential

and the mitigation of resistance" explores and discusses the role of different regulatory sequences on the potential for Cas9 gene drives to generate resistance alleles which would break said drives.

The authors start by outlining the known issues around generating functional gene drives, and the scenarios via which resistance may develop and be selected for. They then detail the development of three new gene drive strains targeting a single locus associated with female fertility, and compare this to their previously published gene drive targeting the same locus.

This is a very interesting topic, and builds nicely on the authors previous work. Overall this a very nicely written and designed set of experiments, with only a few minor comments.

See below my comments ordered by section.

Abstract: I found the reference to modifications to germline regulatory sequences slightly misleading. This work compared several endogenous regulatory sequences, but didn't start editing or modifying these sequences. Could the authors clarify this statement

Introduction:

This section is well written and lays out the rest of the MS clearly

L72 - this sentence doesn't make sense grammatically

Results:

Data analysis - The use of M-W tests and KW tests is fine - though the authors could consider whether using a linear model would eliminate the small risk of inflated type 1 error rates from running mutliple comparisons. In addition - a G-test/Chi-square approach to rates of inheritance would allow the calculation of odds ratios between lines e.g. males inherit at X rate compare to females - and direct rather than indirect comparisons between lines.

I would also caution that the use of these nonparametric tests indicates that the data has a non-normal distribution, in which case the use of means and s.e. should be avoided and replaced with median and IQR instead.

It would also be good to see the full statistics includede here e.g. test statistics and sample sizes, not just the p value

In Figure 2 - I struggled to compare these back to the numbers listed in text - are these different replicates that have been put together for analysis, if so this needs to be made explicit. In addition details in the legends should make it clear what points, lines and error bars represent.

L211 - It would have been nice to see egg laying data as well as larval output, to look at egg laying and viability

L253 - Brown-Forsythe and Welche are two different types of ANOVA - so which one was used?

Figure 4 - refers to R2 as non-resistant mutations and should be corrected

L316 - elaborated on later in the discussion but worth emphasising - that efficient drives can be release at low numbers and be as effective (if not as quick) at reaching high frequency - is a powerful finding

L329 - the pooling method could be more explicit - rather than refer to another MS briefly outline sample types and numbers

L362 - In the creation of resistant mutants there is not much discussion of the role of mosaicism in the vas2 results. Why do you think you get more r2 alleles? Is it because the increased rates of mosaicism mean you detect these in individuals that also have uncut functional alleles?

L370 - You outline a readily testable idea - that these different alleles results are stochastic and not based on selection - even without performing the experiment, it would be nice to see a brief outline of how you would confirm that

L374 - speculation on the idea that there are fewer r1 allele variants in the 'new drive' there could also be other explanations? Lakc of mosaicism in these lines means fewer alleles are able to restore fertility to 100%? Or that timing of ediitng plays a role in the rate of NHEJ, so fewer indels generated?

Reviewer #3: In this study, the authors assess the performance of several promoters for Anopheles gambiae Cas9-based gene drives. They find that the Zpg promoter has superior performance compared to the Nos and especially the Exu promoters in terms of drive inheritance. The Zpg promoter also outperforms the previously utilized Vas2 promoter by reducing somatic expression, thus restoring partial fertility to females with the gene drive. Overall, this is a useful paper that provides new insights into gene drive mechanisms. The study is technically sound, assuming that the comments raised below can be addressed.

Some of the results presented in this paper have already been described in a paper published by the same group in Nature Biotechnology in 2018. However, an earlier version of the current paper was available as a preprint (https://www.biorxiv.org/content/10.1101/360339v1?versioned=true) at that time, and this preprint is cited in the Nature Biotechnology paper.

Specific comments:

1. Within each construct, did the individuals with lower fertility also have lower drive inheritance among their offspring? Exu seems to have a different horizontal axis scale than the other four panels of Figure 2, which the authors might want to adjust for ease of comparison. Why is there no statistically significant difference between the Nos male drive inheritance between paternal and maternal drive alleles? Can this be double-checked? It looks like a fairly sizable difference.

2. Why was the wild-type fecundity different for each promoter, when these insects should have been free of the transgene? Were they part of the same batch as the transgenic mosquitoes of each promoter, or were they all independent sets of experiments? This should be noted. If the latter, this possibly indicates confounding batch effects when assessing the relative fecundity of the different transgenic lines. In this case, probably only the larger differences should be considered statistically significant, or an alternative analysis should be performed that takes batch effects into account using all wild-type crosses for each comparison.

3. Why was male fecundity reduced for nos and exu (but not vasa and zpg) if the target gene only affects female fertility? Could this be a line effect (the line of transgenics simply being less healthy in some cases due to the transgenesis itself, rather than the specific transgenes) or a batch effect as described above?

4. Why was fecundity not determined for the vasa males with drive mothers? Why did these males have slightly biased inheritance toward the gene drive if they were heterozygous for a resistance allele? Also, “ND” should be defined in the legend.

5. The cage data seems to deviate from the model simulations, especially for eggs laid. This could be due to a model parameter mismatch, but a presumably more likely explanation would be that the effective population size in the cages was lower than the census size, yet the latter was used in the model. It would therefore be interesting to adjust the model to a lower population size if possible. This issue of effective population size should at least be noted in the results.

6. Lines 266-271: in this experiment, the authors did not specifically select individuals which did not develop resistance alleles in the embryo to test for shadow drive. Since resistance allele formation in the embryos was near total for vasa, any “signal” for shadow drive would be minimal. For the other promoters, lack of any resistance allele formation in the embryo indicates that there is little to no maternal deposition, which would also rule out the possibility of shadow drive (if no Cas9 at early stages, none would be available later in the germline). At best, the authors can probably rule out “extremely strong” shadow drive (note that the Drosophila studies found at most moderate shadow drive).

7. Lines 292-294: early germline resistance alleles were also seen in references 10, 13, and 32, which could be cited here as well.

8. The references on lines 423-424 might not be the most appropriate for showing that multiplexing improves the robustness of drives. Reference 21 didn’t involve using multiple gRNAs to improve the efficiency of a drive (the gRNA targeted other sites that were not involved in the main drive), and reference 37 was a different form of gene drive and thus not fully relevant to the question of multiplexed gRNAs in homing drives. Reference 12 would be good here, as would this new paper: https://www.pnas.org/content/early/2020/09/11/2004373117

In line 425, reference 37 did successfully reduce r1 resistance alleles, possibly through targeting constrained sites, but the above PNAS reference would also be a suitable demonstration of this. Really, though, only reference 8 conclusively shows the importance of constrained target sites.

9. The authors should provide their Mathematica modeling code as a supplement or in a permanent online repository such as GitHub.

10. A new paper has recently used the nos promoter in Anopheles and should probably be cited: https://www.pnas.org/content/117/37/22805

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Bruce A. Hay

Reviewer #2: No

Reviewer #3: No

Decision Letter 1

Gregory S Barsh, Owain Rhys Edwards

5 Dec 2020

* Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. *

Dear Dr Nolan,

Thank you very much for submitting your Research Article entitled 'Regulating the expression of gene drives is key to increasing their invasive potential and the mitigation of resistance' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important topic but identified some concerns that we ask you address in a revised manuscript

We therefore ask you to modify the manuscript according to the review recommendations. Your revisions should address the specific points made by each reviewer.

In addition we ask that you:

1) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our archive. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Owain Rhys Edwards, Ph.D.

Guest Editor

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: All of my concerns have been addressed adequately.

Reviewer #2: This is my second review of The manuscript "Regulating the expression of gene drives is key to increasing their invasive

potential and the mitigation of resistance" I am pleased to see that my original queries have all been addressed, and in my opinion satisfactory responses to the other reviewer comments as well.

This is a welcome new piece of research to the field of gene drive development and I will be happy to see it published

Reviewer #3: The authors have addressed some of my points, but there are still some remaining issues I feel should be addressed before publication.

1. Differences in inheritance between paternal and maternal alleles in the Nos male drive

The authors note that they double checked and found that there are indeed no significant differences. This seems strange, so I ran a Mann-Whitney test myself. Indeed, it was not significant (p=0.1). However, the difference between the female lines (with either male or female drive parents) only had p=0.03 instead of p<0.001 as shown in the figure. I’d therefore suggest rechecking these statistics.

2. Difference in wild-type fecundity for the different promoters:

The authors state in their response that “Given variability in bloodmeal batch/insectary conditions etc we find it most robust to have a matched wild type control. We have noted this in the methods as per the reviewers suggestion”.

This is good, but keep in mind that the controls did indeed have different performance. The authors cannot therefore assume that each control batch is suitable for comparison. The differences between experiments could well have been accounted for by their paired control, but it’s also possible that there is an individual batch effect that can separately affect each batch within the paired experiments. For example, the wild-type control in the vasa batch may have had worse than “usual” fecundity, but the vasa samples could have been fine. The wild-type samples in the Exu experiments could have had better than average fecundity, but that doesn’t mean that the Exu samples within this experiment themselves were also having a good day, thus indicating that the Exu mosquitoes have reduced fecundity. Instead, they could be performing average, with Exu not reducing fecundity at all.

Thus, some of the conclusions about fecundity being reduced in some lines should probably be softened in the results section, and the possibility of these batch effects noted there in the results, not just the methods. Looking at this, I suspect that the Exu mosquitoes might not actually have reduced fecundity, and even the Zpg female reduction and the nos reduction are somewhat questionable (though based on the zpg/dsx paper, the Zpg fecundity reduction is likely quite reliable).

3. Reduced fecundity in nos-CRISPRh males

I am glad to see that the authors now discuss the anomalous reduction in male fecundity. However, I would encourage mention of the above point - that the reduction in fecundity could just be due to batch effects of the experiment and not an actual feature of the drive.

4. Deviations between cage data and model simulations.

I’m generally happy with how the authors revised this. However, I feel they should also mention that variation in male mating success has a large impact on the level of stochastic variation in the cages.

5. Shadow drive.

The authors state in their reply that “While this experiment was not looking for vasa-driven shadow drive of a gene drive allele it was designed with the sensitivity to pick up vasa-driven shadow drive of the r1 resistant allele since it was balanced against a wild type cleavable allele.”

Yes, I understand this. However, shouldn’t the r1 allele be able to do shadow drive only if a wild-type allele is available for conversion? It looks like most wild-type alleles were converted to resistance alleles in the early embryo in this experiment (only about 5% appear to have remained wild-type), hence the reduction in power because they would not be available for conversion in the germline. I thus don’t think the authors can generally rule out shadow drive at the level of the Drosophila studies, even though very high levels of shadow drive can indeed be ruled out.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Bruce A Hay

Reviewer #2: No

Reviewer #3: No

Decision Letter 2

Gregory S Barsh, Owain Rhys Edwards

22 Dec 2020

Dear Dr Nolan,

We are pleased to inform you that your manuscript entitled "Regulating the expression of gene drives is key to increasing their invasive potential and the mitigation of resistance" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Owain Rhys Edwards, Ph.D.

Guest Editor

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-20-01181R2

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Gregory S Barsh, Owain Rhys Edwards

23 Jan 2021

PGENETICS-D-20-01181R2

Regulating the expression of gene drives is key to increasing their invasive potential and the mitigation of resistance

Dear Dr Nolan,

We are pleased to inform you that your manuscript entitled "Regulating the expression of gene drives is key to increasing their invasive potential and the mitigation of resistance" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Alice Ellingham

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Cleavage by CRISPRh can generate resistant mutations as a by-product of error-prone end-joining.

    After cleavage by the nuclease, the majority of target sites will be repaired by homology-directed repair (HDR), leading to a copying over of the CRISPRh allele called homing. A small fraction of targets may remain unmodified or may repair perfectly, resulting in a target that can be cleaved upon re-exposure by the nuclease. Chromosomes that are repaired by end-joining may generate a mutant target site that can no longer be cleaved by the nuclease. If the target site is essential (i.e. a female fertility gene), then a mutation that disrupts the function of the target gene, called an r2 mutation, will be selected out of the population. Mutations that re-code a functional target gene, called an r1 mutation, are resistant to the gene drive and will come under strong selection in presence of the drive.

    (TIF)

    S2 Fig. Comparison of cage data with deterministic model results incorporating percentage change in parameter estimates.

    (A) Increasing the fertility of heterozygous zpg-CRISPRh females by up to 80% can accurately predict the experimental data, suggesting the fertility assays underestimate their true fecundity. Note that for (A), W/D female fertilities with maternal/paternal parental effects are varied together, keeping their ratio constant. (B) A small increase in the homing rates of both males and females can have a dramatic effect on the spread of the gene drive during the early generations. By increasing the homing rate estimates of males, similar to that of females, the improved rate of spread better resembles experimental observation. (C) The resilience of the gene drive within the populations increases when the fertility of females with at least one resistant functional allele (r1) is reduced. The reduced output in progeny of these females slows the spread of r1 alleles and thus, allows the drive to spread closer to fixation and to exert a longer lasting and stronger reproductive load on the population. These modelling data suggest that small cage experiments and phenotypic assays provide crude estimates of fertility and drive, and thus both modelling and large-cage testing are needed to better capture and estimate strain performance.

    (TIF)

    S3 Fig. Depletion of wild-type target site alleles and formation of mutations caused by parentally deposited nuclease from different gene drive constructs.

    zpg-CRISPRh (‘Zpg’), nos-CRISPRh (‘Nos’)or vas2-CRISPRh (‘Vas’) were crossed to a resistant strain (homozygous for the r1 allele 203-GAGGAG) to generate F1 heterozygotes containing both a gene drive and resistant allele (GD/r1). F1 heterozygote males (M) and females (F) and r1/r1 homozygote females (control) were crossed to wild type and their non-drive F2 progeny analysed by pooled amplicon sequencing across the target site in AGAP007280. (A) Amplicon sequencing results from F2 individuals with genotype WT/r1 (left) and their F3 progeny derived from the F2 crossed to WT (right) are plotted to show the fraction of novel resistant (“R”) alleles (‘Proportion of novel R’, top). (B) Amplicon sequencing results from F2 individuals with genotype WT/r1 (left) and their F3 progeny derived from the F2 crossed to WT (right) are plotted to show the fraction of WT alleles (‘Depletion of WT ‘, middle). Frequencies expected by Mendelian inheritance of the WT allele are indicated (dashed line). Deposited nuclease significantly depleted WT and generated novel R for nos-CRISPRh and vas2-CRISPRh females in the F2, but not zpg-CRISPRh females, or males of any class (Ordinary one-way ANOVA with Dunnett's multiple comparisons test, ****: p < 0.0001, ***: p < 0.001, *: p < 0.05, ns: non-significant). (C) Rates of embryonic EJ were estimated based upon the relative frequencies of novel R alleles in the F2 (left) and F3 (right). F2 estimates were calculated from the frequency of novel R alleles amongst the sum of WT and novel R (left). F3 estimates were calculated by multiplying the frequency of novel R by 4, the dilution factor expected due to additional WT alleles received from the parents (right). A minimum of 128 individuals were sequenced for each condition in the F2 and F3 generations and the number of founder F1 individuals is indicated (n). A summary of this data is shown in Fig 3B and 3C.

    (TIF)

    S1 Data. Raw Data for Figs 26 Excel file, tabulated according to figure.

    Includes all raw data points, lists of test statistics and sample sizes.

    (XLSX)

    S2 Data. Summary data for amplicon sequencing experiments reported for Fig 3 (testing of deposited nuclease activity).

    (XLSX)

    S1 Text. Supplementary Methods describing the mathematical modelling in detail.

    (DOCX)

    S1 Table. Model parameters for zpg-CRISPRh.

    (DOCX)

    S2 Table. Additional parameters for stochastic model for zpg-CRISPRh.

    (DOCX)

    S3 Table. Primers used in this study to assemble the transformation vectors.

    (DOCX)

    S4 Table. Promoter and terminator sequences used in gene drive constructs.

    (DOCX)

    S5 Table. The proportions of germline stem cells of different genotypes arising from paternal effects.

    (DOCX)

    S6 Table. Genotype fitnesses and the proportion of each type of gamete produced by each genotype.

    (DOCX)

    Attachment

    Submitted filename: response to reviewers PLoS Gen (1).docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All raw data used for the assembly of all figures is included as supplementary excel files. Raw sequencing reads (amplicon sequencing) from experiments described in this project is deposited at the European Nucleotide Archive under Project ID: PRJEB37873.


    Articles from PLoS Genetics are provided here courtesy of PLOS

    RESOURCES